Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNational Institute of Respiratory Diseases, Mexico
About this trial
The aim of this study is to analyze the effect of enriched formula with omega-3 in the 30-day incidence infection and inflammatory response following lung resection surgery in lung cancer patients.
Eligibility criteria
Qualifiers
Lung cancer diagnosis
Elective surgery for lung resection schedule at least four days before surgery
Signed informed consent.
Disqualifiers
Acute or chronic organ failure as hepatic or renal insufficiency
Patients with fish-allergy
History of any surgery within 3 months
Immunocompromised patients
Trial design
Treatments tested in this trial
- Fish oil enteral supplementation
- Fish oil oral supplementation
- Enteral nutrition without fish oil
- Oral nutritional supplement without fish oil
Treatment groups
310 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov